Objectives: In 2009, the Society for Vascular Surgery (SVS) developed objective performance goals (OPGs) to define the therapeutic benchmarks for catheter-based revascularization in critical limb ischemia (CLI) based upon outcomes from randomized trials of lower extremity bypass (SVS OPG cohort). Current real-world performance relative to these benchmarks remains unknown. The objective of this study was to determine whether lower extremity bypass (LEB) and infrainguinal endovascular intervention (IEI) performed for CLI in a contemporary national cohort met OPG safety benchmarks.
Objectives: In 2009, the Society for Vascular Surgery (SVS) developed objective performance goals (OPGs) to define the therapeutic benchmarks for catheter-based revascularization in critical limb ischemia (CLI) based upon outcomes from randomized trials of lower extremity bypass (SVS OPG cohort). Current real-world performance relative to these benchmarks remains unknown. The objective of this study was to determine whether lower extremity bypass (LEB) and infrainguinal endovascular intervention (IEI) performed for CLI in a contemporary national cohort met OPG safety benchmarks.
Methods: SVS OPG criteria were applied to 11,043 revascularizations for CLI performed from 2011 to 2015 in the National Surgical Quality Improvement Project (NSQIP) vascular-targeted modules. Primary 30-day safety OPGs, including major adverse cardiac events (MACE), major adverse limb events (MALE), and amputation, were calculated for all OPG-eligible NSQIP LEB (bypass with single-segment saphenous vein, n ¼ 3,835; Table I ) and IEI (defined as angioplasty, stenting, and/or atherectomy, n ¼ 3,526; Table I ) cohorts and within anatomic high-risk (infrapopliteal disease) and clinical high-risk (age >80 and tissue loss) cohorts defined by SVS OPG criteria. These were compared with SVS OPGs using c 2 comparisons. Results: Compared with the SVS OPG cohort, the NSQIP LEB and IEI cohorts had fewer anatomic high-risk patients (LEB: 51% vs SVS OPG 60%; P < .0001; IEI: 17% vs SVS OPG: 60%; P < .0001), and the LEB cohort had fewer clinical high-risk patients (LEB: 11% vs SVS OPG: 16%; P < .0001). In the OPG-eligible NSQIP cohorts, LEB and IEI were associated with lower 30-day MACE but higher 30-day MALE and amputation compared with the SVS OPG cohort (Table II) . Among anatomic high-risk patients, the NSQIP LEB and IEI cohorts again had lower MACE and higher MALE and amputation compared with the SVS OPG cohort (Table II) . Among clinical high-risk patients, IEI was associated with lower MACE, and LEB and IEI had MALE and amputation similar to the SVS OPG cohort (Table II) .
Conclusions: In contemporary real-world practice, LEB and IEI for CLI surpassed SVS OPG safety benchmarks for MACE but failed to meet SVS OPG safety benchmarks for MALE and amputation in the entire OPG-eligible NSQIP cohort as well as in anatomic high-risk patients. Revascularization for CLI is now associated with lower cardiovascular morbidity than anticipated based on OPG trial data, and OPG benchmarks deserve further evaluation. Additional investigation is needed to determine why limb-related outcomes after bypass and endovascular intervention for CLI remain suboptimal. Objectives: Over the last 15 years, the demographic and clinical characteristics of surgical patients have changed. During this period, endovascular surgery has also supplanted open surgical bypass as the most frequently used approach in patients with atherosclerotic disease of the aortoiliac segment. We sought to determine whether these trends in patients undergoing aortofemoral bypass (AFB) for aortoiliac occlusive disease (AOD) have impacted the patient profile and outcomes following surgical bypass.
Methods: Using a prospectively maintained institutional database, we identified patients who underwent AFB for AOD. Patients were divided into two cohorts: the historical cohort (HC), 1985 to 1999, and the contemporary cohort (CC), 2000 to 2015. Demographic and clinical data, procedural information, postoperative complications, and follow-up were extracted. Two-group comparison of continuous variables was performed using the Student t-test or Wilcoxon rank sum based on normality of distribution, c 2 for discrete variables, and logrank for survival analysis.
Results: There were a total of 359 cases: 226 in the HC and 133 cases in the CC. The CC had more women (56.4% vs 43.8%; P ¼ .02) smokers (87.2% vs 67.7%; P ¼ .001), and patients on dialysis (3.0% vs 0.0%; P ¼ .009, Table I ). There were fewer patients with comorbid coronary artery disease (32.3% vs 47.3%; P ¼ .005). The CC included more patients who had undergone prior aortoiliac endovascular intervention that had failed (17.3% vs 4.8%; P ¼ .0001), and there was a nonsignificant trend toward an increased number of patients undergoing AFB for critical limb ischemia (50.4% vs 40.7%; P ¼ .07) as opposed to claudication symptoms. Overall and major morbidity were similar in both cohorts (Table II) . Thirty-day mortality was similar and <1% in both cohorts, but 10-year survival was higher in the CC (67.7% vs 52.6%; P ¼ .02). Ten-year primary patency was higher in the HC (75.8% vs 90.8%; P ¼ .02), but secondary patency and limb salvage were similar in both cohorts, with the latter >95% in both cases.
Conclusions: In the contemporary era, patients undergoing AFB for AOD are more likely to have undergone aortoiliac endovascular intervention, and to be females, smokers, and have comorbid dialysisdependent end-stage renal disease. Although long-term primary patency is lower among patients in the CC, during which a substantial subset of AOD patients are being treated primarily via the endovascular approach, secondary patency and limb salvage have not worsened, and long-term survival has increased. These changing characteristics should be considered when benchmarking for reintervention rates and other outcomes.
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VESS13. Peroneal Bypass vs Endovascular Peroneal Intervention for Critical Limb Ischemia
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Objectives: The peroneal artery is a well-established target for bypass in patients with critical limb ischemia (CLI). The objective of this study was to compare the outcomes of peroneal bypass and endovascular peroneal intervention in terms of wound healing and limb salvage in patients with CLI.
Methods: Patients presenting between 2006 and 2013 with CLI (Rutherford IV-VI) and isolated peroneal runoff were included in the study. They were divided into patients who underwent bypass to the peroneal artery and those who underwent endovascular peroneal artery intervention. Demographics, comorbidities, and follow-up data were recorded. Wounds were classified by the Wound, Ischemia, foot Infection (WIfI) score. Primary end points included wound healing, amputation rate, and patency.
Results: Included were 200 limbs with peroneal bypass and 138 limbs with endovascular peroneal intervention, with mean follow-up of 24.0 6 26.3 and 14.5 6 19.1 months, respectively (P ¼ .0001). The two groups were comparable in comorbidities with the exception of the endovascular group having more patients with cardiac and renal disease and diabetes mellitus but fewer patients with smoking history. WIfI scores showed smaller, less severely infected wounds but more severe ischemia in the bypass group. The aggregate WIfI scores were similar between groups, as was the pedal runoff score (Table I) . Perioperatively, bypass patients had higher rates of myocardial infarction (4.5% vs 0%; P ¼ .012) and incisional complications (13.0% vs 4.4%; P ¼ .008). At 12 months, the bypass group compared to the endovascular group had better primary patency (47.9% vs 23.4%; P ¼ .002) and primary assisted patency (63.6% vs 42.2%; P ¼ .003) and a trend toward better secondary patency (74.2% vs 63.5%; P ¼ .11). There were no differences in the rate of reintervention (33.0% vs 42.0%; P ¼ .09), wound healing (52.6% vs 37.7%; P ¼ .14), or major amputation-free survival (81.5% vs 74.7%; P ¼ .38). In a multivariate analysis, neuropathy was associated with improved wound healing, while WIfI wound score, cancer, chronic renal insufficiency, and smoking were associated with decreased wound healing. Treatment modality was not a significant predictor (Table II) .
Conclusions: Endovascular peroneal artery intervention offers lower patency rates but improved perioperative morbidity and similar wound healing and limb salvage rates compared to peroneal bypass. In appropriately selected patients, endovascular intervention for isolated peroneal runoff is a low-risk intervention that may be sufficient to heal ischemic foot wounds and avoid limb loss.
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